I

India Pesticides Ltd
NSE:IPL

Watchlist Manager
India Pesticides Ltd
NSE:IPL
Watchlist
Price: 151.23 INR 1.02% Market Closed
Market Cap: ₹17.4B

India Pesticides Ltd
Investor Relations

India Pesticides Limited manufactures agro-chemical products. The company is headquartered in Lucknow, Uttar Pradesh and currently employs 800 full-time employees. The company went IPO on 2021-07-05. The firm is primarily engaged in the business of manufacture, sale, and distribution of insecticides, fungicides, herbicide, and various other agrochemical products. The company manufactures both technicals and formulations in agrochemical and active pharma ingredients for pharma industry. Its technicals products include herbicides, such as Aclonifen, Pretilachlor, and Prosulfocarb; fungicides, such as Thiram, Ziram, Cymoxanil, Folpet, and Captan; insecticides, such as Diafenthiuron and Thiamethoxam, and intermediates, such as Pthalamide and Tetra Hydro Pthalamide. Its formulations include IPL Dollar, IPL Vardan, IPL Vecto, IPL Trim WG, IPL-Sodhit DS, IPL-Sodhit WS, Captax-50, IPL Natraj, Sanjeevni, IPL Trim, IPL Talwar SC, and Carbine-50. Its active pharma ingredients include Anti-Fungal Drugs and Anti-Scabies Drugs. The company supplies its products to United States of America, Australia, Europe, Africa, South America and Asia.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Feb 11, 2026
AI Summary
Q3 2026

Strong Revenue Growth: India Pesticides reported Q3 revenue of INR 229 crores, up 31% year-on-year, and 9-month revenue of INR 808 crores, a 28% increase.

Profitability Expansion: Net profit for Q3 reached INR 23 crores, up 41% YoY, with PAT margin improving to 10%. EBITDA margin rose to 18%.

Exports & Domestic Strength: Export sales grew 28% YoY, driven by Europe and Australia, while domestic sales rose 33%. The company maintains a balanced market mix.

Capacity & CapEx: Capacity utilization reached 65% in Q3. Capacity expansions are ongoing, with further CapEx of INR 80–100 crores for Shalvis and INR 25–30 crores for Sandila planned.

Stable Pricing: Realizations remained stable across domestic and export markets, with limited price softening in a few products.

Positive Outlook: Management reaffirmed guidance for 20% revenue growth and 18–20% margins in FY '27, and outlined a roadmap to INR 3,000 crores revenue in five years.

Key Financials
Revenue
INR 229 crores
Revenue (9 months)
INR 808 crores
Net Profit
INR 23 crores
Net Profit (9 months)
INR 89 crores
EBITDA
INR 41 crores
EBITDA Margin
18%
PAT Margin
10%
Capacity Utilization
65%
Export Revenue (Q3)
INR 96 crores
Domestic Revenue (Q3)
INR 130 crores
Other Earnings Calls

Management

Mr. Dheeraj Kumar Jain
Chief Executive Officer
No Bio Available
Mr. Satya Prakash Gupta
Chief Financial Officer
No Bio Available
Mr. Rajendra Singh Sharma
Executive ? Whole Time Director
No Bio Available
Mr. Narendra Dev Nath Ojha
Company Secretary & Compliance Officer
No Bio Available
Dr. Kuruba Adeppa
Whole Time Director
No Bio Available
Mr. Ramchandra Murthy Bhagi
Senior VP & Unit Head of Sandila Manufacturing Unit
No Bio Available

Contacts

Address
UTTAR PRADESH
Lucknow
Swarup Cold Storage Compound, Water Works Road, Aishbagh
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett